about
General protocol for the synthesis of functionalized magnetic nanoparticles for magnetic resonance imaging from protected metal-organic precursors.A d-f heteronuclear complex for dual-mode phosphorescence and magnetic resonance imaging.Paramagnetic hollow silica nanospheres for in vivo targeted ultrasound and magnetic resonance imaging.Tumor cell specific and lysosome-targeted delivery of nitric oxide for enhanced photodynamic therapy triggered by 808 nm near-infrared light.Small Gold Nanorods: Recent Advances in Synthesis, Biological Imaging, and Cancer Therapy.Photo-controlled targeted intracellular delivery of both nitric oxide and singlet oxygen using a fluorescence-trackable ruthenium nitrosyl functional nanoplatform.In situ sulfidation of Cu2O by endogenous H2S for colon cancer theranosticsA smart theranostic platform for photoacoustic and magnetic resonance dual-imaging-guided photothermal-enhanced chemodynamic therapyTumor microenvironment-activated NIR-II reagents for tumor imaging and therapySurface Plasmon Resonance-Enhanced Photoacoustic Imaging and Photothermal Therapy of Endogenous H2 S-Triggered Au@Cu2 OPaclitaxel-Induced Ultrasmall Gallic Acid-Fe@BSA Self-Assembly with Enhanced MRI Performance and Tumor Accumulation for Cancer TheranosticsMn-Porphyrin-Based Metal-Organic Framework with High Longitudinal Relaxivity for Magnetic Resonance Imaging Guidance and Oxygen Self-Supplementing Photodynamic TherapyA smart off-on copper sulfide photoacoustic imaging agent based on amorphous-crystalline transition for cancer imagingSmart nanomedicine agents for cancer, triggered by pH, glutathione, H2O2, or H2SMacrophages-Mediated Delivery of Small Gold Nanorods for Tumor Hypoxia Photoacoustic Imaging and Enhanced Photothermal TherapypH and Glutathione Synergistically Triggered Release and Self-Assembly of Au Nanospheres for Tumor Theranostics
P50
Q30810350-96108490-E7B9-4968-89F4-1B3FE30D2185Q34385819-87930815-BAD5-49DD-BCC9-3DBE0F8617DEQ39007656-493824AD-3050-4D0F-9A2E-3C3CA95FD0EFQ46648852-D5780610-31F9-49BB-B177-B4EBE3A78970Q48586326-B7958F74-4F28-46EA-91D2-26A0BBE04C5EQ48690753-6AFBAC91-F5B6-4CDC-B9CD-2907E8CC45C2Q57279613-AE389B33-115B-4E78-AACB-8728534EC993Q89773864-9F8DBA36-E472-4D90-8CC4-251C7305C86CQ89989441-C4990C09-F220-44BF-81FE-73E6B1C541FCQ90075527-C54ED4CB-2D07-4F59-BC04-EEA10357E7F8Q90771936-11637C90-08B8-472F-9F1C-43D09719AD93Q90871235-8015314A-C384-4DAC-B90C-42C586898E0BQ91475022-AB9E5718-AB2D-4C12-8859-B038E44597A8Q92798725-01026368-739B-4277-90F9-666A7C34CEB9Q92965734-5D3F48A0-09B9-4621-A22D-DF46DCF11485Q93022929-667C41A0-3CBE-439D-969B-5D73085EFDB2
P50
description
researcher ORCID ID = 0000-0002-6696-1651
@en
name
Lu An
@ast
Lu An
@en
Lu An
@nl
type
label
Lu An
@ast
Lu An
@en
Lu An
@nl
prefLabel
Lu An
@ast
Lu An
@en
Lu An
@nl
P31
P496
0000-0002-6696-1651